Press releases

February, 2020

Subscription period for FRISQ’s rights issue begins today

Today, February 4, 2020, marks the start of the subscription period for FRISQ Holding AB’s fully guaranteed Rights Issue, in which the general public also has the opportunity to subscribe for shares without subscription rights. The extraordinary general meeting of January 20, 2020, approved the resolution of FRISQ Holding AB’s board of directors to conduct a Rights Issue of a maximum of 7,175,460 shares at a subscription price of SEK 9.00 per share, totalling at most approximately SEK 64.6 million. The...

FRISQ publishes prospectus in connection with fully guaranteed rights issue of approximately SEK 64.6 million

Extraordinary General Meeting of FRISQ Holding AB (“FRISQ” or the “Company”) approved on 30 January 2020 the Board of Directors resolution to conduct a new share issue of a maximum 7,175,460 shares at a subscription price of SEK 9.00 per share, with preferential rights for the Company’s existing shareholders (the “Rights Issue”). The proceeds from the Rights Issue may bring proceeds to the Company at a maximum of approximately SEK 64.6 million, before deduction of costs related to the Rights Issue....
January, 2020

High levels of patient engagement among FRISQ customers – enabling healthier patients and more effective care

The results of an analysis of FRISQ Care, conducted during the fall and based on data from several customers, show extremely high levels of patient engagement – around 80% – among a variety of patient groups. The results confirm FRISQ’s ability to help healthcare systems enable healthier, more satisfied patients while also saving time and costs. In 2019, forward-looking healthcare plans began using FRISQ Care as a tool for both public and private care providers in providing regular care. This has e...

Announcement from FRISQ’s extra general meeting

The extra general meeting in Frisq Holding AB (publ) (”FRISQ” or the ”Company”) was held today on 30 January 2020 and the following resolutions were passed by the meeting.

Year-end report 2019

Financial summary fourth quarter 2019 Reported net revenue was 0.03 MSEK (2.6) Net revenue for the quarter was 0.53 MSEK Reclassification of EU financed commercially based projects to Other Income was 0.5 MSEK. Other revenue amounted to 0.6 MSEK (0.4) Earnings per share amounted to -0.9 SEK (-0.7) Cash-flow amounted to -21.0 MSEK (-10.6) Cash and cash equivalent on December 31, was 26.7 MSEK (41.7) Financial summary full year 2019 Reported net revenue was 1.9 MSEK (5.2) Other revenue amounted to...

FRISQ Signs Letter of Intent With Leading U.S. Academic Hospital

FRISQ and Dartmouth–Hitchcock Medical Center (DHMC) in New Hampshire, United States, have signed a letter of intent to enter into a licensing agreement under which FRISQ Care will initially be used in the treatment of heart failure. During the coming period, the plan is to configure FRISQ Care to enable DHMC and its regional care providers on the U.S. east coast to create a unique, interactive care plan for each patient that provides continuous communication and information exchange between health c...

FRISQ to conduct a fully guaranteed rights issue of approximately SEK 64.6 million

INSIDER INFORMATION: The Board of Directors of FRISQ Holding AB (“FRISQ” or the “Company”) has today resolved, pending the subsequent approval of an Extraordinary General Meeting, to conduct a new share issue of a maximum 7,175,460 shares at a subscription price of SEK 9.00 per share, with preferential rights for the Company’s existing shareholders (the “Rights Issue”). The proceeds from the Rights Issue may bring proceeds to the Company at a maximum of approximately SEK 64.6 million, before deduct...